Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “S-1 Plus Oxaliplatin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT01997957
What this trial is testing

A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Zhu Xu 110
Testing effectiveness (Phase 2)UnknownNCT03403101
What this trial is testing

The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer

Who this might be right for
Carcinoma, Pancreatic Ductal
Fudan University 65
Large-scale testing (Phase 3)Study completedNCT01515748
What this trial is testing

Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Sanofi 530
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05524974
What this trial is testing

Clinical Study of Camrelizumab, Apatinib Mesylate and Nab-paclitaxel Combined With Oxplatin and S-1 in the Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Genotypes

Who this might be right for
Locally Advanced Gastric Cancer
Fujian Medical University 203
Not applicableUnknownNCT03001726
What this trial is testing

To Observe the Efficacy and Safety by Comparing Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With Radical Resection Versus Chemotherapy Alone in Advanced Gastric Cancer With Single Non-curable Factor.

Who this might be right for
Gastric Cancer
Shanghai Zhongshan Hospital 228
Testing effectiveness (Phase 2)Active Not RecruitingNCT05026905
What this trial is testing

A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer

Who this might be right for
Phase II, Open-label, Parallel 2-arm, Multi-center
National Health Research Institutes, Taiwan 66
Testing effectiveness (Phase 2)UnknownNCT05052931
What this trial is testing

Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Jianjun Yang 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06383078
What this trial is testing

HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer

Who this might be right for
Efficacy and Safety
The First Affiliated Hospital with Nanjing Medical University 120
Testing effectiveness (Phase 2)Study completedNCT02539225
What this trial is testing

Ramucirumab in Participants With Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Metastatic Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Eli Lilly and Company 191
Large-scale testing (Phase 3)Active Not RecruitingNCT03691454
What this trial is testing

Compare Neoadjuvant DOS Combined With Toripalimab Versus SOX Combined With Toripalimab in Locally Advanced Gastric Adenocarcinoma

Who this might be right for
Gastric Adenocarcinoma
Peking University 248
Testing effectiveness (Phase 2)UnknownNCT03990103
What this trial is testing

S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant Ascites

Who this might be right for
Metastatic Gastric Adenocarcinoma
China Medical University, China 66
Early research (Phase 1)Study completedNCT01928524
What this trial is testing

Chemotherapy for Patients With Cancer of the Stomach

Who this might be right for
First-line Treatment for Patients With Non-resectable Gastric Cancer or Cancer of the Esophagus or
Per Pfeiffer 34
Testing effectiveness (Phase 2)UnknownNCT06396585
What this trial is testing

The Efficacy and Safety of Tislelizumab Combined With Anlotinib and S1 Plus Oxaliplatin as Neoadjuvant Therapy for the Locally Advanced Adenocarcinoma of Esophagogastric Junction

Who this might be right for
Immunotherapy Gastroesophageal Junction
Fujian Cancer Hospital 28
Testing effectiveness (Phase 2)UnknownNCT01227239
What this trial is testing

Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting

Who this might be right for
Rectal Carcinoma
Japan Clinical Cancer Research Organization 45
Large-scale testing (Phase 3)Ended earlyNCT02867839
What this trial is testing

Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Peking University Cancer Hospital & Institute 29
Testing effectiveness (Phase 2)Study completedNCT00721916
What this trial is testing

Randomized Phase II Study of SOL for Untreated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Taiho Pharmaceutical Co., Ltd. 107
Testing effectiveness (Phase 2)UnknownNCT00524706
What this trial is testing

Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Shizuoka Cancer Center 42
Testing effectiveness (Phase 2)UnknownNCT01180153
What this trial is testing

Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma)

Who this might be right for
Biliary Tract Cancer
Peking University Cancer Hospital & Institute 40
Testing effectiveness (Phase 2)UnknownNCT03007446
What this trial is testing

The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric Cancer

Who this might be right for
Gastric Cancer
Chinese PLA General Hospital 20
Testing effectiveness (Phase 2)UnknownNCT05218148
What this trial is testing

SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma

Who this might be right for
HER2-positiveLocally Advanced Solid TumorImmunotherapy+4 more
Aiping Zhou 44
Next Page